Estudo randomizado | Ressonância magnética reduz à metade os casos de “overdiagnosis” no rastreamento do câncer de próstata.

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening – New England Journal of Medicine (link para o resumo – $ para o texto completo)

Comunicado de imprensa: MRI can cut overdiagnoses in prostate-cancer screening by half – Karolinska Institutet

Artigos relacionados: RCT: MRI-targeted biopsy safely reduces the need for biopsy in more than one-third of men at risk for prostate cancer E Meta-Analysis: Negative Predictive Value of MRI in the Detection of Clinically Significant Prostate Cancer E Study: MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis E Review: The Use of MRI and PET Imaging Studies for Prostate Cancer Management E Meta-Analysis: MRI plus Targeted Biopsy vs. Systematic Biopsy Alone for the Diagnosis of Prostate Cancer E Cochrane Review: MRI Pathway vs. Systematic Biopsy for Detecting Prostate Cancer E Meta-analysis: Clinical Utility of MRI in the Decision-making Process Before Radical Prostatectomy E Research: Biparametric MRI (simpler, faster) May Be Used to Exclude Aggressive Disease and Avoid Unnecessary Biopsies in Men with Clinical Suspicion of Prostate Cancer E Research: MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis E Multiparametric MRI in the Detection of Clinically Significant Prostate Cancer